| scholarly article | Q13442814 |
| P50 | author | Li Yang | Q87823668 |
| P2093 | author name string | Yi Shen | |
| Yongjun Zhu | |||
| Changli Lu | |||
| Xiaoli Fan | |||
| Ruoting Men | |||
| Maoyao Wen | |||
| P2860 | cites work | Liver cirrhosis | Q34010340 |
| Histological scoring of chronic hepatitis. | Q51982801 | ||
| EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis | Q59384401 | ||
| Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy | Q77058192 | ||
| Frequency and nature of the variant syndromes of autoimmune liver disease | Q77058224 | ||
| Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease | Q79711877 | ||
| Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis | Q80022983 | ||
| Autoimmune hepatitis | Q82936688 | ||
| Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases | Q88636602 | ||
| Diagnosis and management of autoimmune hepatitis | Q34118165 | ||
| Autoimmune acute liver failure: proposed clinical and histological criteria | Q34822608 | ||
| A meta-analysis of ursodeoxycholic acid therapy versus combination therapy with corticosteroids for PBC-AIH-overlap syndrome: evidence from 97 monotherapy and 117 combinations | Q36167366 | ||
| Prognostic indicators of survival in patients with compensated and decompensated cirrhosis | Q37019451 | ||
| Classification of chronic viral hepatitis: a need for reassessment | Q37032966 | ||
| Overlap syndromes among autoimmune liver diseases | Q37182958 | ||
| Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue | Q37808546 | ||
| Review article: overlap syndromes and autoimmune liver disease | Q38027909 | ||
| Evaluation of histological staging systems for primary biliary cirrhosis: correlation with clinical and biochemical factors and significance of pathological parameters in prognostication | Q38183450 | ||
| The Management of Autoimmune Hepatitis Patients with Decompensated Cirrhosis: Real-World Experience and a Comprehensive Review | Q38925324 | ||
| Clinical significance of the Scheuer histological staging system for primary biliary cholangitis in Japanese patients | Q40534871 | ||
| Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid | Q43875853 | ||
| Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. | Q44143314 | ||
| Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. | Q46134815 | ||
| Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis | Q46502311 | ||
| Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome | Q46852534 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | overlap syndrome | Q7113759 |
| gastroenterology | Q120569 | ||
| P304 | page(s) | 1965492 | |
| P577 | publication date | 2018-08-02 | |
| P1433 | published in | Canadian Journal of Gastroenterology & Hepatology | Q5030241 |
| P1476 | title | Efficacy and Safety of Immunosuppressive Therapy for PBC-AIH Overlap Syndrome Accompanied by Decompensated Cirrhosis: A Real-World Study | |
| P478 | volume | 2018 |
Search more.